Skip to main content

Neuroone Medical Technologies Corp

NMTC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001500198

In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Neuroone Medical Technologies Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of NMTC: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders1221+9
Shares1.77M1.27M−499.9K (−28.2%)
Value$2.99M$1.53M−$1.46M (−48.9%)

New holders (11)

Institutions that held Neuroone Medical Technologies Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to NMTC in Q4 2022
InstitutionSharesValue% of portfolio
Mayo Clinic181,754$218.1K0.12%
Susquehanna International Group, LLP85,926$103.1K0.00%
Citadel Advisors LLC36,098$43.3K0.00%
Virtu Financial LLC14,939$18.0K0.00%
Morgan Stanley2,699$3.24K0.00%
UBS Group AG1,198$1.44K0.00%
Belpointe Asset Management LLC682$8180.00%
Money Concepts Capital Corp113$1360.00%
Bank of America Corp34$400.00%
Simplex Trading, LLC270$00.00%
Advisor Group Holdings, Inc.350$00.00%

Sold out (2)

Institutions that held Neuroone Medical Technologies Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of NMTC in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Newport Capital Group, LLC18,348$24.0K
Cutler Group LP300$0